Perfil
Patrick Hargutt founded Stanley Capital Partners LLP in 2020, where he is working as Founding Partner from 2020.
Mr. Hargutt also currently works at Stanley Lab, Inc., as Founding Director from 2021, Laboratoire X.O, as Board Director from 2022, and Noden Pharma DAC, as Director from 2020.
Mr. Hargutt also formerly worked at Healthcare AI Acquisition Corp., as Chief Financial Officer & Director and Monarch Alternative Capital (Private Equity), as Vice President from 2018 to 2019.
Mr. Hargutt received his undergraduate degree in 2010 from Technische Universität München.
Cargos activos de Patrick Hargutt
| Empresas | Cargo | Inicio |
|---|---|---|
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements. | Fundador | 01/01/2020 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Director/Miembro de la Junta | 01/09/2020 |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines | Director/Miembro de la Junta | 01/09/2022 |
Stanley Lab, Inc.
Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy | Director/Miembro de la Junta | 01/03/2021 |
Antiguos cargos conocidos de Patrick Hargutt.
| Empresas | Cargo | Fin |
|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Director Financiero/CFO | 12/06/2023 |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies. | Inversor de Capital Privado | 31/10/2019 |
Formación de Patrick Hargutt.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanley Lab, Inc.
Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy | Retail Trade |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements. | Finance |
Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Bolsa de valores
- Insiders
- Patrick Hargutt
















